Bernadette’s Last Hope for Beating Cancer: Will CAR-T Cell Therapy Cure Her Non-Hodgkin's Lymph

There is hope for people suffering from treatment resistant blood cancers like Non-Hodgkin's Lymphoma and Leukemia. It's CAR-T Cell Immunotherapy. Bernadette Deely received the treatment at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. CAR-T Cell Therapy uses the body's own immune cells to fight cancer. But exactly how does it work, and will it save Bernadette?

The University of Maryland School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research, and provide the best patient care and community service to Maryland and beyond.